# XLIMus Drug Eluting Stent: a randomIzed Controlled Trial to Assess Endothelization

> **NCT03745053** · NA · COMPLETED · sponsor: **Cardionovum GmbH** · enrollment: 180 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Xlimus DES Implantation during coronary angioplasty
- **DEVICE:** Synergy DES Implantation during coronary angioplasty

## Key facts

- **NCT ID:** NCT03745053
- **Lead sponsor:** Cardionovum GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-05
- **Primary completion:** 2023-09-02
- **Final completion:** 2023-09-02
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2024-02-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03745053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03745053, "XLIMus Drug Eluting Stent: a randomIzed Controlled Trial to Assess Endothelization". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03745053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*